An advanced millifluidic gut-on-a-chip platform designed to simulate human host-microbe interactions and intestinal barrier function. This versatile technology enables real-time monitoring and high-fidelity modeling of biological systems for the evaluation of probiotics, drug efficacy, and disease mechanisms, offering a reliable alternative to animal testing in pre-clinical research.
The Integrated Probiotic Gut-on-a-Chip Evaluation Platform is a sophisticated organ-on-chip technology designed to model human intestinal physiology for advanced biomedical research. By bridging the gap between traditional in vitro methods and complex animal models, this platform enables highly reliable, real-time studies of host-microbe interactions. It provides researchers and industrial developers with a physiologically relevant environment to evaluate new probiotic formulations, active ingredients, and therapeutic responses, ultimately streamlining pre-clinical development and supporting personalized medicine initiatives.
The technology has reached a mature stage of validation, demonstrated through successful application in major industrial environments across both pharmaceutical and probiotic sectors. The platform has been used in multi-institutional research initiatives and is supported by peer-reviewed validation in high-impact scientific publications. It is currently being prepared for market transition, with opportunities for licensing or co-development. (TRL 7)
Politecnico di Milano (Polytechnic University of Milan) is a leading public technical university based in Milan, with multiple campuses across Lombardy and a large applied research enterprise. Companies engage via co‑located labs, shared prototyping and testing facilities, and an on‑campus innovation district and startup accelerator. Internships and thesis collaborations make it easy to scope pilots, access talent, and run joint development on site or at partner locations. Research is backed by competitive European and national funding, including European Commission programs such as Horizon Europe, alongside regional support and direct industry contracts. A dedicated technology transfer office manages IP, licensing, spinout formation, and sponsored‑research agreements.